financetom
Business
financetom
/
Business
/
Affirm Stock Rallies After Strong Q4 Earnings, Upbeat Q1 Guidance: What To Know
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Affirm Stock Rallies After Strong Q4 Earnings, Upbeat Q1 Guidance: What To Know
Aug 31, 2024 4:19 AM

Affirm Holdings Inc. ( AFRM ) shares are trading higher following strong fourth-quarter earnings and upbeat first-quarter guidance. Here's a look at the details from the report. 

The Details: Affirm reported quarterly losses of 14 cents per share, which beat the analyst consensus estimate of losses of 51 cents by 72.55%. Quarterly revenue came in at $659 million, which beat the consensus estimate by 9.17% and represents a 47.82% increase over the same period last year.

Read Next: What’s Going On With Trump Media & Technology Stock After New Indictment Against Donald Trump?

GMV grew more than 30% and revenue grew more than 45%.

Transactions on the Affirm network grew 42% year over year to 24.7 million in the quarter.

Transactions per active consumer reached 4.9 in the fourth quarter with consumers transacting quarterly or more often accounting for approximately 40% of all Affirm transactions in the fiscal year.

Affirm’s network had over 300,000 integrated active merchants at the end of fiscal year 2024.

“We delivered excellent results in both the fourth fiscal quarter as well as full 2024 fiscal year. Just over two years ago, we set a public goal of achieving profitability on an adjusted operating income basis exiting FY'23. As our FY'23 ended, we were proud to report that we achieved this goal. Adjusted operating income in FQ4'23 was just $15 million, but it had a plus

sign in front of it!” Affirm CEO Max Levchin wrote in a letter to shareholders.

Outlook: Affirm sees first-quarter revenue in a range of $640 million to $670 million, versus the $603.661 million estimate.

AFRM Price Action: According to Benzinga Pro, Affirm Holdings ( AFRM ) shares are up 14.79% after-hours at $36.30at the time of publication Wednesday.

Read Also:

 Kerrisdale Capital Is Short Lumen Technologies: Here’s What To Know

Find out what's new and innovative from the people who know at Benzinga Fintech Deal Day & Awards on Nov. 19 in New York City. It's where capital markets fintech leaders and investors connect. Click here to find out more!

Image: Courtesy of Affirm Holdings, Inc. ( AFRM ) 

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Copyright 2023-2026 - www.financetom.com All Rights Reserved